Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1 : Th2 cytokine ratios

Grass pollen immunotherapy is the only treatment for hayfever that is both effective and confers long-term benefit. Immunotherapy may act by altering the local nasal mucosal T helper type 2 (Th2) to type 1 (Th1) cytokine balance either by down-regulation and/or immune deviation of T-lymphocyte respo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Wachholz, Petra A, Nouri-Aria, Kayhan T, Wilson, Duncan R, Walker, Samantha M, Verhoef, Adrienne, Till, Stephen J, Durham, Stephen R
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 2002
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1782637/
https://ncbi.nlm.nih.gov/pubmed/11849315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2567.2002.01338.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak